Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis
The skin microbiome at lesion sites in patients with atopic dermatitis (AD) is characterized by dysbiosis. Although the administration of dupilumab, an IL-4Rα inhibitor, improves dysbiosis in the bacterial microbiome, information regarding the fungal microbiome remains limited. This study administer...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2024-01-01
|
| Serie: | Microorganisms |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/2076-2607/12/1/224 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|